1. Home
  2. MRSN vs AWRE Comparison

MRSN vs AWRE Comparison

Compare MRSN & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • AWRE
  • Stock Information
  • Founded
  • MRSN 2001
  • AWRE 1986
  • Country
  • MRSN United States
  • AWRE United States
  • Employees
  • MRSN N/A
  • AWRE N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • MRSN Health Care
  • AWRE Technology
  • Exchange
  • MRSN Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • MRSN 40.7M
  • AWRE 34.6M
  • IPO Year
  • MRSN 2017
  • AWRE 1996
  • Fundamental
  • Price
  • MRSN $0.36
  • AWRE $1.87
  • Analyst Decision
  • MRSN Strong Buy
  • AWRE
  • Analyst Count
  • MRSN 5
  • AWRE 0
  • Target Price
  • MRSN $5.75
  • AWRE N/A
  • AVG Volume (30 Days)
  • MRSN 2.3M
  • AWRE 48.2K
  • Earning Date
  • MRSN 08-12-2025
  • AWRE 08-07-2025
  • Dividend Yield
  • MRSN N/A
  • AWRE N/A
  • EPS Growth
  • MRSN N/A
  • AWRE N/A
  • EPS
  • MRSN N/A
  • AWRE N/A
  • Revenue
  • MRSN $34,006,000.00
  • AWRE $16,576,000.00
  • Revenue This Year
  • MRSN N/A
  • AWRE N/A
  • Revenue Next Year
  • MRSN $1.30
  • AWRE N/A
  • P/E Ratio
  • MRSN N/A
  • AWRE N/A
  • Revenue Growth
  • MRSN N/A
  • AWRE N/A
  • 52 Week Low
  • MRSN $0.26
  • AWRE $1.35
  • 52 Week High
  • MRSN $2.83
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 46.82
  • AWRE 67.00
  • Support Level
  • MRSN $0.35
  • AWRE $1.69
  • Resistance Level
  • MRSN $0.39
  • AWRE $2.30
  • Average True Range (ATR)
  • MRSN 0.03
  • AWRE 0.13
  • MACD
  • MRSN -0.00
  • AWRE 0.02
  • Stochastic Oscillator
  • MRSN 12.30
  • AWRE 38.57

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: